11 Jun 2019
Follicum raises SEK 56m to finance important steps for the pipeline. A directed share issue strengthens the ownership base. Increased activity for a diabetes project could add important value going forward.
Read the full report (Swedish) here.
We use cookies to provide you with the best possible experience of our website Read more
Assistant
Telephone: +49 30 809 33 47-12
@
Senior Associate
Telephone: +49 40 300 836-14
Equity Analyst
Telephone: +46 70 508 00 51
Head of Equity Research
Telephone: +46 76 235 03 20
Office Management & Accounting
Telephone: +44 20 8017 6020
Head of Equity Sales
Telephone: +46 73 382 10 82
Managing Partner
Telephone: +45 4199 8252
Senior Advisor Life Sciences
Telephone: +46 73 312 44 90
Partner
Telephone: +49 89 255 49 53-15
Telephone: +46 70 496 18 15
Director
Telephone: +49 89 255 49 53-12
Telephone: +49 40 300 836-19
Vice President
Telephone: +49 40 300 836-21
Telephone: +49 30 809 33 47-20
Telephone: +46 70 246 99 88
Telephone: +46 707 40 68 58
Associate
Telephone: +49 40 300 836-20
Telephone: +44 20 80176020
IT&Telecom Expert
Head of Marketing
Telephone: +49 40 300 836 18
Telephone: +49 40 300 836 10
Telephone: +45 2634 9031
Telephone: +49 40 300 836-24
Telephone: +49 89 255 49 53 26
Telephone: +49 89 255 49 53-18
Telephone: +46 73 850 35 59
Office Management & PA to Michael Moritz
Telephone: +49 30 809 33 47-10
Head of Operations
Telephone: +49 30 809 33 47 16
Telephone: +49 40 300 836-11
Telephone: +49 30 809 33 47-13
Senior Equity Analyst
Telephone: +46 70 434 90 03
Telephone: +45 4199 8251
Office Management & HR
Telephone: +49 89 255 495 310
Telephone: +45 2621 0543
Telephone: +49 89 255 49 53-17
Telephone: +49 89 255 49 53-11
Telephone: +49 40 300 836-15
Telephone: +44 77 1347-8286
Business Development & Marketing
Telephone: +44 20 8017 6017
Telephone: +46 761 71 11 60
Telephone: +49 30 809 33 47-25
Telephone: +49 30 809 3347 33
Telephone: +46 73 840 55 66
Telephone: +49 40 300 836-28
